Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Mandatory HIV screening of persons aged 15-65 follows HCV testing of baby boomers.

Blanco F.

AIDS Rev. 2013 Apr-Jun;15(2):134. No abstract available.

PMID:
23847791
2.

HIV and HCV testing for young drug users in Rhode Island.

Pugatch D, Anderson BJ, O'Connell JV, Elson LC, Stein MD.

J Adolesc Health. 2006 Mar;38(3):302-4.

PMID:
16488833
3.

Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.

Zou S, Dodd RY, Stramer SL, Strong DM; Tissue Safety Study Group.

N Engl J Med. 2004 Aug 19;351(8):751-9.

4.

Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection.

Huckans MS, Blackwell AD, Harms TA, Indest DW, Hauser P.

AIDS. 2005 Oct;19 Suppl 3:S106-15.

PMID:
16251805
5.
6.

The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.

Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, Cavuslu S.

Transfus Med. 2010 Jun;20(3):152-9. doi: 10.1111/j.1365-3148.2009.00987.x. Epub 2010 Jan 5.

PMID:
20059750
7.

Plans to expand AIDS testing alarm activists.

[No authors listed]

AIDS Read. 2006 Aug;16(8):388, 392. No abstract available.

PMID:
16933371
8.

Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors?

Alswaidi FM, O'Brien SJ.

J Epidemiol Community Health. 2010 Nov;64(11):989-97. doi: 10.1136/jech.2009.093302. Epub 2009 Oct 12.

PMID:
19822552
9.

Canada introduces hepatitis C test.

[No authors listed]

AIDS Patient Care STDS. 1999 Apr;13(4):250. No abstract available.

PMID:
10351901
10.

Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions.

Nübling CM, Heiden M, Chudy M, Kress J, Seitz R, Keller-Stanislawski B, Funk MB.

Transfusion. 2009 Sep;49(9):1850-8. doi: 10.1111/j.1537-2995.2009.02212.x. Epub 2009 May 14.

PMID:
19453976
11.

Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007.

Spradling PR, Richardson JT, Buchacz K, Moorman AC, Finelli L, Bell BP, Brooks JT; HIV Outpatient Study Investigators.

J Acquir Immune Defic Syndr. 2010 Mar;53(3):388-96. doi: 10.1097/QAI.0b013e3181b67527.

PMID:
19738485
12.
13.

Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk.

Taylor LE, DeLong AK, Maynard MA, Chapman S, Gholam P, Blackard JT, Rich J, Mayer KH.

AIDS Patient Care STDS. 2011 Oct;25(10):571-7. doi: 10.1089/apc.2011.0106. Epub 2011 Aug 22.

14.

Testing for HIV-1 infection in a public developmental center.

Blair CR, Gill CE, Taylor HM, McGowan CC, Charles PD.

Tenn Med. 2009 Sep;102(9):51-3.

PMID:
19791542
15.

A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death.

Edler C, Wulff B, Schröder AS, Wilkemeyer I, Polywka S, Meyer T, Kalus U, Pruss A.

J Med Microbiol. 2011 Jul;60(Pt 7):920-6. doi: 10.1099/jmm.0.027763-0. Epub 2011 Mar 24.

PMID:
21436373
16.

Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.

Hennessey KA, Kim AA, Griffin V, Collins NT, Weinbaum CM, Sabin K.

J Urban Health. 2009 Jan;86(1):93-105. doi: 10.1007/s11524-008-9305-8. Epub 2008 Jul 12.

17.

Hepatitis C virus infection in patients with tuberculosis in Central Brazil.

Reis NR, Lopes CL, Teles SA, Matos MA, Carneiro MA, Marinho TA, Filho JA, Espírito-Santo MP, Lampe E, Martins RM.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1397-402. doi: 10.5588/ijtld.10.0636.

PMID:
22283901
18.

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP; National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group.

N Engl J Med. 2004 Aug 19;351(8):760-8.

19.

Experience of hepatitis C testing among injecting drug users in Sydney, Australia.

Day CA, White B, Thein HH, Doab A, Dore GJ, Bates A, Holden J, Maher L.

AIDS Care. 2008 Jan;20(1):116-23. doi: 10.1080/09540120701426524.

PMID:
18278622
20.

Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.

Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL.

Transfusion. 2010 Jul;50(7):1495-504. doi: 10.1111/j.1537-2995.2010.02622.x. Epub 2010 Mar 12.

PMID:
20345570
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk